NON-HEMATOLOGIC MALIGNANCY

Clinical trials for NON-HEMATOLOGIC MALIGNANCY explained in plain language.

Never miss a new study

Get alerted when new NON-HEMATOLOGIC MALIGNANCY trials appear

Sign up with your email to follow new studies for NON-HEMATOLOGIC MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug trial tests hope for Hard-to-Treat tumors

Disease control Completed

This study tested a drug called surufatinib in Japanese patients with advanced neuroendocrine tumors that had stopped responding to standard treatments. The first part checked the drug's safety and the best dose, while the second part measured how well it shrank tumors. A total o…

Matched conditions: NON-HEMATOLOGIC MALIGNANCY

Phase: PHASE1, PHASE2 • Sponsor: Hutchmed • Aim: Disease control

Last updated Mar 16, 2026 15:26 UTC

NON-HEMATOLOGIC MALIGNANCY

Get alerted when new NON-HEMATOLOGIC MALIGNANCY trials appear

New drug trial tests hope for Hard-to-Treat tumors